A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2

F Saccà, G Puorro, A Brunetti, G Capasso, A Cervo… - Journal of …, 2015 - Springer
Abstract Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder. Lithium is
able to stimulate autophagy, and to reduce Ca 2+ efflux from the inositol-1, 4, 5-triphosphate …

Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3

X Chen, TS Tang, H Tu, O Nelson, M Pook… - Journal of …, 2008 - Soc Neuroscience
Spinocerebellar ataxia type 3 (SCA3), also known as Machado–Joseph disease (MJD), is
an autosomal-dominant neurodegenerative disorder caused by a polyglutamine expansion …

Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model

K Watase, JR Gatchel, Y Sun, E Emamian… - PLoS …, 2007 - journals.plos.org
Background Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited
neurodegenerative disorder characterized by progressive motor and cognitive dysfunction …

Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2

J Liu, TS Tang, H Tu, O Nelson, E Herndon… - Journal of …, 2009 - Soc Neuroscience
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominantly inherited,
neurodegenerative disease caused by an expansion of polyglutamine tracts in the cytosolic …

Spinocerebellar ataxia type 2 is associated with Parkinsonism and Lewy body pathology

M Takao, M Aoyama, K Ishikawa, Y Sakiyama… - Case …, 2011 - casereports.bmj.com
Clinical phenotype of individuals with spinocerebellar ataxia 2 (SCA2) is characterised by
cerebellar ataxia and cognitive impairment. Although L-dopa-responsive Parkinsonism is …

[PDF][PDF] Cognitive changes in spinocerebellar ataxia type 2

M Vališ, J Masopust, J Bažant, Z Říhová… - Neuroendocrinology …, 2011 - academia.edu
OBJECTIVES: Cognitive disorders and dementia occur in 19 to 42% of patients with
spinocerebellar ataxia type 2 (SCA2). Neuropsychological tests can reveal executive …

Spinocerebellar ataxia type 1: one-year longitudinal study to identify clinical and MRI measures of disease progression in patients and presymptomatic carriers

A Nigri, L Sarro, A Mongelli, A Castaldo, L Porcu… - The Cerebellum, 2022 - Springer
Abstract Spinocerebellar ataxias type 1 (SCA1) is an autosomal dominant disease usually
manifesting in adulthood. We performed a prospective 1-year longitudinal study in 14 …

Spinocerebellar ataxia type 3 presenting as an L-DOPA responsive dystonia phenotype in a Chinese family

E Wilder-Smith, EK Tan, HY Law, Y Zhao, I Ng… - Journal of the …, 2003 - Elsevier
The clinical spectrum of spinocerebellar ataxia 3 (SCA 3) disease is wide and varied. We
describe a Chinese patient with a mutation at the SCA 3 locus with clinical features of …

Motor cortical dysfunction develops in spinocerebellar ataxia type 3

MA Farrar, S Vucic, G Nicholson, MC Kiernan - Clinical Neurophysiology, 2016 - Elsevier
Objective Spinocerebellar ataxia type 3 (SCA3) is an inherited neurodegenerative disorder
characterized by cerebellar ataxia and variable expression of clinical features beyond the …

[HTML][HTML] Therapeutic prospects for spinocerebellar ataxia type 2 and 3

I Bezprozvanny, T Klockgether - Drugs of the Future, 2009 - ncbi.nlm.nih.gov
Abstract Spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3) are autosomal-dominant
neurodegenerative disorders. SCA2 primarily affects cerebellar Purkinje neurons. SCA3 …